Randomized, controlled trial of recombinant human α-interferon in patients with chronic hepatitis B

Gastroenterology

Volumn 95, Issue 5, 1988, Pages 1318-1325

  Hoofnagle, Jay H ^a,b,c   Peters, Marion ^a,b,c   Mullen, Kevin D ^a,b,c   Jones, D Brian ^a,b,c   Rustgi, Vinod ^a,b,c   Di Bisceglie, Adrian ^a,b,c   Hallahan, Claire ^a,b,c   Park, Yoon ^a,b,c   Meschievitz, Carlton ^a,b,c   Jones, E Anthony ^a,b,c  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ASPARTATE AMINOTRANSFERASE; RECOMBINANT ALPHA INTERFERON A; RECOMBINANT ALPHA2B INTERFERON;

CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; FATIGUE; HEPATITIS B; HUMAN; LEUKOPENIA; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; SUBCUTANEOUS DRUG ADMINISTRATION; VERTIGO;

ADOLESCENT; ADULT; AGED; CHRONIC DISEASE; CLINICAL TRIALS; DNA, VIRAL; DNA-DIRECTED DNA POLYMERASE; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B; HEPATITIS B CORE ANTIGENS; HEPATITIS B VIRUS; HUMAN; INTERFERON ALFA-2B; INTERFERON TYPE I, RECOMBINANT; MALE; MIDDLE AGE; PROSPECTIVE STUDIES; RANDOM ALLOCATION;

EID: 0023771584     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/0016-5085(88)90367-8     Document Type: Article

References (26)

1. Hepatocellular carcinoma and the hepatitis B virus: evidence for a causal association
2. Chronic viral hepatitis
3. Hepatocellular carcinoma and hepatitis B virus
4. Survival in chronic hepatitis B: an analysis of 379 patients
5. Effect of vidarabine on chronic hepatitis B virus infection
6. Adenine arabinoside therapy in HBsAg-positive chronic liver disease: a controlled study
7. Randomized controlled trial of adenine arabinoside monophosphate for chronic type B hepatitis
8. Comparative efficacy of adenine arabinoside 5′ monophosphate and prednisone withdrawal followed by adenine arabinoside 5′ monophosphate in the treatment of chronic active hepatitis type B
9. Combination of short-term prednisolone and adenine arabinoside in the treatment of chronic hepatitis B
10. Adenine arabinoside monophosphate in combination with human leukocyte interferon in the treatment of chronic hepatitis B: a randomized, double-blind, placebo-controlled trial
11. Acyclovir enhances the antiviral effect of Interferon in chronic hepatitis B
12. Antiviral treatment in chronic infection with hepatitis B virus
13. Antiviral treatment of chronic hepatitis B virus infection. I. Changes in viral markers with interferon combined with adenine arabinoside
14. A randomized study of the effect of adenine arabinoside monophosphate (4 or 8 week courses) versus lymphoblastoid interferon on hepatitis B virus (HBV) replication
15. Vidarabine monophosphate and human leukocyte interferon in chronic hepatitis B infection
16. Pilot study of recombinant human α-interferon for chronic type B hepatitis
17. Prolonged recombinant leukocyte interferon treatment of chronic hepatitis B
18. Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection
19. Immunoglobulin M antibody to hepatitis B core antigen in chronic type B hepatitis
20. Immunologic effects of interferon alpha in man: treatment with human recombinant interferon alpha suppresses in vitro immunoglobulin production in patients with chronic type B hepatitis
21. Peroxidaseanti-peroxidase detection of hepatitis B surface and core antigen in liver biopsy specimens from patients with chronic type B hepatitis
22. Psychiatric complications of long-term interferon alpha therapy
23. Diminished responsiveness of homosexual men to antiviral therapy for HBsAg-positive chronic liver disease
24. Prednisone withdrawal followed by recombinant alpha interferon in the treatment of chronic hepatitis B (abstr)
25. Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection